Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics is a research paper published in Molecular Therapy (2022). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA197098-01
U.S. Department of Veterans Affairs
Grant: BX005260-01
NIGMS NIH HHS
Grant: T32 GM008444
BLRD VA
Grant: I01 BX005260
NCI NIH HHS
Grant: R01 CA197098
National Institutes of Health
Grant: 1R01CA197098-01A1
Roles of miR-129 in colorecal cancer
National Institutes of Health
FWCI
0.94
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals